Compare Stocks

→ The Sneaky IRS Tax Law that's Sweeping the U.S. (From Birch Gold) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FHLT Future Health ESG	$12.00	$11.38	$9.97 ▼ $15.05	$71.28M	-0.12	9,336 shs	17 shs
PEAR Pear Therapeutics		$0.00	$0.03 ▼ $6.74	$4.17M	0.45	7.75 million shs	N/A
PIII P3 Health Partners	$0.70 -3.8%	$0.81	$0.44 ▼ $5.56	$220.25M	1.26	376,959 shs	297,102 shs

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FHLT Future Health ESG	0.00%	-4.00%	0.00%	+3.09%	+20.36%
PEAR Pear Therapeutics	0.00%	0.00%	0.00%	0.00%	-96.77%
PIII P3 Health Partners	+13.32%	+54.79%	-10.17%	-34.10%	-60.17%

Dave Ramsey Shocks Millions With US Dollar Lunacy (Ad)

Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.

GET THE FREE GUIDE

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
FHLT Future Health ESG	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PEAR Pear Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PIII P3 Health Partners	1.3662 of 5 stars	3.3	2.0	0.0	0.0	2.0	0.8	0.6

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FHLT Future Health ESG	N/A	N/A	N/A	N/A
PEAR Pear Therapeutics	N/A	N/A	N/A	N/A
PIII P3 Health Partners	2.50	Moderate Buy	$4.75	581.30% Upside

Current Analyst Ratings

Latest PIII, PEAR, and FHLT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/1/2024	PIII P3 Health Partners	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
4/1/2024	PIII P3 Health Partners	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral
3/14/2024	PIII P3 Health Partners	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$9.00 ➝ $4.50

(Data available from 5/7/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FHLT Future Health ESG	N/A	N/A	N/A	N/A	($1.56) per share	N/A
PEAR Pear Therapeutics	$12.69M	0.00	N/A	N/A	$0.22 per share	0.00
PIII P3 Health Partners	$1.27B	0.17	$0.10 per share	6.79	$0.45 per share	1.55

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FHLT Future Health ESG	-$50K	N/A	0.00	∞	N/A	N/A	-9.79%	-0.28%	N/A
PEAR Pear Therapeutics	-$75.49M	-$0.22	N/A	N/A	N/A	-594.70%	-217.85%	-95.20%	N/A
PIII P3 Health Partners	-$57.77M	-$0.65	N/A	N/A	N/A	-4.56%	-120.85%	-6.54%	5/8/2024 (Confirmed)

Latest PIII, PEAR, and FHLT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/8/2024	N/A	PIII P3 Health Partners	-$0.19	N/A	+$0.19	N/A	N/A	N/A
3/28/2024	Q4 2023	PIII P3 Health Partners	-$0.19	-$0.22	-$0.03	-$0.22	$309.80 million	$346.86 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
FHLT Future Health ESG	N/A	N/A	N/A	N/A	N/A
PEAR Pear Therapeutics	N/A	N/A	N/A	N/A	N/A
PIII P3 Health Partners	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FHLT Future Health ESG	N/A	0.02	0.02
PEAR Pear Therapeutics	N/A	1.48	1.48
PIII P3 Health Partners	0.76	0.55	0.55

Ownership

Institutional Ownership

Company	Institutional Ownership
FHLT Future Health ESG	24.57%
PEAR Pear Therapeutics	71.17%
PIII P3 Health Partners	7.75%

Insider Ownership

Company	Insider Ownership
FHLT Future Health ESG	57.20%
PEAR Pear Therapeutics	30.70%
PIII P3 Health Partners	17.06%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
FHLT Future Health ESG	2,021	5.94 million	2.54 million	Not Optionable
PEAR Pear Therapeutics	300	142.74 million	98.92 million	Not Optionable
PIII P3 Health Partners	400	315.90 million	262.01 million	Not Optionable

PIII, PEAR, and FHLT Headlines

Source	Headline
	P3 Health Partners (PIII) to Release Quarterly Earnings on Wednesday marketbeat.com - May 3 at 10:32 AM
	P3 Health Partners Schedules First Quarter 2024 Earnings Release and Conference Call businesswire.com - May 2 at 8:00 AM
	P3 Health Partners Inc. (PIII) May Report Negative Earnings: Know the Trend Ahead of Q1 Release zacks.com - May 1 at 11:05 AM
	P3 Health Partners to Present at the 23rd Annual Needham Virtual Healthcare Conference businesswire.com - April 3 at 8:00 AM
	P3 Health Partners: Q4 Earnings Insights benzinga.com - March 28 at 7:59 PM
	P3 Health Partners Inc. Reports Revenue Growth and Affirms 2024 Guidance, Despite Net Loss finance.yahoo.com - March 28 at 7:59 PM
	P3 Health Partners Announces Fourth Quarter and Full Year 2023 Results businesswire.com - March 28 at 4:05 PM
	P3 Health to report Q4 and full year 2023 earnings on March 28 uk.investing.com - March 17 at 3:04 PM
	P3 Health Partners to Participate in the Jefferies Value Based Healthcare Summit businesswire.com - February 28 at 8:00 AM
	P3 Health Partners to Present at the TD Cowen 44th Annual Healthcare Conference businesswire.com - February 19 at 8:00 AM
	P3 Health Partners to Participate in The 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference finance.yahoo.com - January 30 at 12:51 PM
	P3 Health Partners Inc.'s (NASDAQ:PIII) Path To Profitability finance.yahoo.com - January 19 at 8:47 AM
	P3 Health Partners reaffirms 2023 guidance, sees 2024 revenue above estimates msn.com - January 10 at 6:58 AM
	Why Health Management Company P3 Health Partners Shares Are Up Today markets.businessinsider.com - January 10 at 6:58 AM
	P3 Health Partners Reaffirms 2023 Guidance, Sees 2024 Revenue Above View; Stock Up markets.businessinsider.com - January 9 at 10:43 PM
	P3 Health Partners Reaffirms Guidance for 2023 and Announces Guidance for 2024 finance.yahoo.com - January 9 at 10:43 PM
	P3 Health Partners to Present at the 42nd Annual J.P. Morgan Healthcare Conference finance.yahoo.com - January 2 at 5:49 PM
	BTIG Research initates P3 Health Partners Inc (PIII) rating to a Buy knoxdaily.com - January 1 at 8:03 PM
	P3 Health Partners Inc Class A PIII morningstar.com - December 17 at 1:39 AM
	Positive Revenue Prospects and Improved Cash Flow: Reasons Behind David Larsen’s Buy Rating for P3 Health Partners markets.businessinsider.com - November 15 at 12:04 AM
	P3 Health Partners Inc. (NASDAQ:PIII) Q3 2023 Earnings Call Transcript finance.yahoo.com - November 12 at 1:24 PM
	P3 Health Partners Inc [PIII] Records 50-Day SMA of $1.7013 knoxdaily.com - November 10 at 8:42 AM
	55,508 businesswire.com - November 8 at 9:09 PM
	P3 Health Partners Announces Third-Quarter and Year-to-Date 2023 Results finance.yahoo.com - November 8 at 4:09 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Stocks Leading the U.S. Agriculture Comeback
April 26, 2024 10:10 AM
View 3 Stocks Leading the U.S. Agriculture Comeback
How to Use Put Debit Spreads to Profit From Falling Stocks
April 26, 2024 9:30 AM
View How to Use Put Debit Spreads to Profit From Falling Stocks
Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 months
April 26, 2024 3:21 AM
View Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 months
Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
April 25, 2024 10:36 AM
View Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
Is Norwegian Cruise Lines Ready to Catch Up to Royal Caribbean?
April 16, 2024 6:15 AM
View Is Norwegian Cruise Lines Ready to Catch Up to Royal Caribbean?

All Headlines

Company Descriptions

Future Health ESG

NASDAQ:FHLT

Future Health ESG Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Dover, Delaware.

Pear Therapeutics

NASDAQ:PEAR

Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.

P3 Health Partners

NASDAQ:PIII

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial